Benitec Biopharma Inc.
BNTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001808898
No open-market purchases or sales by Benitec Biopharma Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $443.3M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Benitec Biopharma Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 21 | 22 | +1 |
| Shares | 1.58M | 1.34M | −242.0K (−15.3%) |
| Value | $2.60M | $1.55M | −$1.05M (−40.3%) |
New holders (5)
Institutions that held Benitec Biopharma Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 53,886 | $62.0K | 0.00% |
| Citadel Advisors LLC | 49,964 | $58.0K | 0.00% |
| Virtu Financial LLC | 47,393 | $55.0K | 0.00% |
| Millennium Management LLC | 25,132 | $29.0K | 0.00% |
| Two Sigma Securities, LLC | 24,270 | $28.0K | 0.00% |
Sold out (4)
Institutions that held Benitec Biopharma Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Atom Investors LP | 37,335 | $87.0K |
| Silverarc Capital Management, LLC | 492,880 | $57.0K |
| BlackRock Inc. | 19,554 | $46.0K |
| Rosenberg Matthew Hamilton | 381 | $1.00K |